Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.
作者信息
Tashjian Armen H, Chabner Bruce A
机构信息
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
出版信息
J Bone Miner Res. 2002 Jul;17(7):1151-61. doi: 10.1359/jbmr.2002.17.7.1151.
PMID:12096828
Abstract
摘要
Zotero 插件